VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
478
New
Increased
Reduced
Closed

Top Buys

1
+$2.49M
2
+$2.46M
3
+$2.31M
4
OXLC
Oxford Lane Capital
OXLC
+$2.19M
5
TKO icon
TKO Group
TKO
+$2.17M

Top Sells

1
+$1.99M
2
+$1.62M
3
+$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
176
Alnylam Pharmaceuticals
ALNY
$59.7B
$665K 0.19%
1,459
MIRM icon
177
Mirum Pharmaceuticals
MIRM
$3.59B
$665K 0.19%
9,066
INSM icon
178
Insmed
INSM
$45.2B
$661K 0.19%
4,587
BKT icon
179
BlackRock Income Trust
BKT
$358M
$660K 0.19%
58,703
-2,049
ARDX icon
180
Ardelyx
ARDX
$1.37B
$658K 0.19%
119,461
UTHR icon
181
United Therapeutics
UTHR
$20.7B
$651K 0.19%
1,553
TARS icon
182
Tarsus Pharmaceuticals
TARS
$3.36B
$645K 0.18%
10,852
ARCC icon
183
Ares Capital
ARCC
$14.8B
$622K 0.18%
30,499
-76
KNSA icon
184
Kiniksa Pharmaceuticals
KNSA
$3.1B
$622K 0.18%
16,026
FSCO
185
FS Credit Opportunities Corp
FSCO
$1.2B
$619K 0.18%
+89,551
TSLX icon
186
Sixth Street Specialty
TSLX
$2.05B
$617K 0.18%
26,990
-2,312
TBPH icon
187
Theravance Biopharma
TBPH
$995M
$612K 0.18%
41,884
HALO icon
188
Halozyme
HALO
$8.03B
$598K 0.17%
8,148
AUPH icon
189
Aurinia Pharmaceuticals
AUPH
$2.12B
$597K 0.17%
53,997
ROIV icon
190
Roivant Sciences
ROIV
$14.1B
$586K 0.17%
38,744
BBIO icon
191
BridgeBio Pharma
BBIO
$13.9B
$582K 0.17%
11,208
FOLD icon
192
Amicus Therapeutics
FOLD
$3.07B
$568K 0.16%
72,025
KRYS icon
193
Krystal Biotech
KRYS
$6.24B
$559K 0.16%
3,167
ONC
194
BeOne Medicines Ltd
ONC
$37.1B
$548K 0.16%
1,607
INCY icon
195
Incyte
INCY
$20.1B
$544K 0.16%
6,420
-23,424
MRCC icon
196
Monroe Capital Corp
MRCC
$140M
$544K 0.16%
77,488
-4,804
NVAX icon
197
Novavax
NVAX
$1.1B
$539K 0.15%
62,153
PTCT icon
198
PTC Therapeutics
PTCT
$6.42B
$535K 0.15%
8,717
BCIC
199
BCP Investment Corp
BCIC
$171M
$529K 0.15%
45,852
+2,233
APLS icon
200
Apellis Pharmaceuticals
APLS
$2.68B
$522K 0.15%
23,073
6 7
8
9 10